Organ-on-a-chip test systems for the development of novel cancer therapies
We are pleased to announce the funding of Wellcome Leap under the HOPE program to develop a novel multi-organ chip with partners from academia and industry. Together with the University of Tübingen, Miltenyi Biotec B.V. & Co. KG and LaVision BioTec GmbH, the project will combine several in vitro models in one test system: lymph node model, tumor models and microenvironment of the tumor will be connected and represent physiological processes as realistically as possible. Ultimately, the test system can be used to assess the efficacy of immunotherapies used to treat cancer.
The complete press release can be found here (only available in German).
